Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: A systematic review and meta-analysis

Clinical Infectious Diseases

Volumn 58, Issue 3, 2014, Pages 330-339

  Chalmers, James D ^a,c   Rother, Catriona ^a   Salih, Waleed ^a   Ewig, Santiago ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Augusta Kranken Anstalt   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

guidelines; healthcare associated infection; meta analysis; mortality; pneumonia

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM ISOLATE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; ENTEROBACTERIACEAE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MEDLINE; META ANALYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIDRUG RESISTANCE; NURSING HOME; PATHOGENESIS; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PUBLISHING; RECEIVER OPERATING CHARACTERISTIC; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

GUIDELINES; HEALTHCARE-ASSOCIATED INFECTION; META-ANALYSIS; MORTALITY; PNEUMONIA;

BACTERIA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA;

EID: 84892772563     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit734     Document Type: Review

References (48)

1. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64:iii1-55.
2. American Thoracic Society/Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
3. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128:3854-62.
4. Ewig S, Welte T, Chastre J, Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10:279-87.
5. Ewig S, Welte T, Torres A. Is healthcare-associated pneumonia distinct entity needing specific therapy? Curr Opin Infect Dis 2012; 25:166-75.
6. Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy and clinical outcomes in healthcare associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 53:107-13.
7. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393-9.
8. Polverino E, Dambrava P, Cilloniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65:354-9.
9. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150:19-26.
10. Brito V, Niederman MS. Healthcare-associated pneumonia is a heter-ogenous disease and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009; 22:316-25.
11. Anand N, Kollef MH. The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP and VAP. Semin Respir Crit Care Med 2009; 30:3-9.
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. JAMA 2000; 283:2008-12.
13. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognostic studies in systematic reviews. Ann Intern Med 2006; 144:427-37.
14. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326:219.
15. Chalmers JD, Mandal P, Singanayagam A, et al. Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis. Intensive Care Med 2011; 37:1409-20.
16. Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community acquired pneumonia. Thorax 2010; 65:878-83.
17. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004; 329:168-9.
18. Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM 2006; 8:19-20.
19. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigation and dealing with publication and other biases in meta-analysis. BMJ 2001; 323:101-5.
20. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51:3568-73.
21. Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multi-drug resistant pathogens in hospitalized patients coming from the community with pneumonia. Clin Infect Dis 2012; 54:470-8.
22. Carrabba M, Zarantonello M, Bonara P, et al. Severity assessment of heathcare-associated pneumonia and pneumonia in immunosuppres-sion. Eur Respir J 2012; 40:1201-10.
23. Fukuyama H, Yamashiro S, Tamaki H, Kishaba T. A prospective comparison of nursing-and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother 2013; 19:719-26.
24. Garcia-Vidal C, Viasus D, Roset A, et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 2011; 17:1659-65.
25. Giannella M, Pinilla B, Capdevilla JA, et al. Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect 2012; 18:786-94.
26. Grenier C, Pepin J, Nault V, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 2011; 66:1617-24.
27. Hoo Lee J, Kim YH. Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted to secondary hospitals. Braz J Infect Dis 2012; 16:321-8.
28. Ishida T, Tachibana H, Ito A, et al. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med 2012; 51:2537-44.
29. Jeon EJ, Cho SG, Shin JW, et al. The difference in clinical presentation between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea. Yonsei Med J 2011; 52:282-7.
30. Jeong BH, Koh WJ, Yoo H, et al. Performances of prognostic scoring systems in patients with healthcare-associated pneumonia. Clin Infect Dis 2013; 56:625-32.
31. Miyashita N, Kawai Y, Akaike H, et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012; 51:585-94.
32. Oshitani Y, Nagai H, Matsui H, et al. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan. J Infect Chemother 2013; 19:579-87.
33. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu, Japan. J Infect Chemother 2011; 17:363-9.
34. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patientsin a Japanese community hospital. Chest 2009; 135:633-40.
35. Simonetti A, Viasus D, Garcia-Vidal C, et al. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia. Clin Microbiol Infect 2012; 18:1149-55.
36. Sugisaki M, Enomoto T, Shibuya Y, et al. Clinical characteristics of healthcare-associated pneumonia in a public hospital in a metropolitan area of Japan. J Infect Chemother 2012; 18:352-60.
37. Umeki K, Tokimatsu I, Yasuda C, et al. Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home acquired (NHAP), HCAP other than NHAP and community-acquired pneumonia. Respirology 2011; 16:856-61.
38. Jung JY, Park MS, Kim YS, et al. Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital. BMC Infect Dis 2011; 11:61.
39. Depuydt P, Putman B, Benoit D, Buylaert W, De Paepe P. Nursing home residence is the main risk factor for increased mortality in healthcare-associated pneumonia. J Hosp Infect 2011; 77:138-42.
40. Madison JM, Irwin RS. Expectorated sputum for community-acquired pneumonia. A Sacred Cow. Arch Intern Med 2004; 164:1725-7.
41. Chalmers JD. ICU admission and severity assessment in community-acquired pneumonia. Crit Care 2009; 13:156.
42. Wunsch H, Angus DC, Harrison DA, Linde-Zwirble WT, Rowan KM. Comparison of medical admissions to intensive care units in the United States and United Kingdom. Am J Respir Crit Care Med 2011; 183:1666-73.
43. Singanayagam A, Singanayagam A, Elder DH, Chalmers JD. Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir J 2011; 39:187-96.
44. Mandal P, Chalmers JD, Choudhury G, Akram AR, Hill AT. Vascular complications are associated with poor outcome in community-acquired pneumonia. QJM 2011; 104:489-95.
45. Chalmers JD, Al-Khairalla M, Short PM, Fardon TC, Winter JH. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother 2010; 65:608-18.
46. Yu VL. Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall and a fatal flaw. Lancet Infect Dis 2011; 11:248-52.
47. Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011; 38:878-87.
48. Polverino E, Torres A. Current perspective ofthe HCAP problem: isitCAP or is it HAP? Semin Respir Crit Care Med 2009; 30:239-48.